Nexus Lifesciences India Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 09-07-2024
- Paid Up Capital ₹ 1.09 M
as on 09-07-2024
- Company Age 17 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.08 Cr
as on 09-07-2024
- Revenue 396.11%
(FY 2021)
- Profit -68.70%
(FY 2021)
- Ebitda 62.19%
(FY 2021)
- Net Worth 0.04%
(FY 2021)
- Total Assets -0.73%
(FY 2021)
About Nexus Lifesciences India
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.09 M.
The company currently has active open charges totaling ₹1.08 Cr.
Kamlesh Jain and Shweta Jain serve as directors at the Company.
- CIN/LLPIN
U24239DL2007PTC157646
- Company No.
157646
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nexus Lifesciences India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamlesh Jain  | Director | 10-Feb-2023 | Current |
| Shweta Jain | Director | 10-Jan-2007 | Current |
Financial Performance of Nexus Lifesciences India.
Nexus Lifesciences India Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 396.11% increase. The company also saw a substantial fall in profitability, with a 68.7% decrease in profit. The company's net worth moved up by a moderate rise of 0.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nexus Lifesciences India?
In 2021, Nexus Lifesciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 20 Nov 2014 | ₹1.08 Cr | Open |
How Many Employees Work at Nexus Lifesciences India?
Unlock and access historical data on people associated with Nexus Lifesciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexus Lifesciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexus Lifesciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
